Yoshihisa Wada

Okayama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease.

Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: January 22, 2026

Endothelial dysfunction accelerates AKI-to-CKD transition by promoting β-catenin activation in macrophages.

Endothelial dysfunction accelerates AKI-to-CKD transition by promoting β-catenin activation in macrophages.

Journal: American journal of physiology. Renal physiology
Published: November 21, 2025

The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuria.

The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuria.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 09, 2025

The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria.

The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 10, 2025

ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice.

ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice.

Journal: Scientific reports
Published: August 21, 2024

CQ IN THE LONG-TERM MANAGEMENT OF ADULT ASTHMATIC PATIENTS WHO ARE NOT ADEQUATELY CONTROLLED WITH INHALED CORTICOSTEROIDS MONOTHERAPY, WHICH IS MORE BENEFICIAL: ADDING A LONG ACTING BETA2 AGONIST OR A LONG ACTING MUSCARINIC ANTAGONIST?

CQ IN THE LONG-TERM MANAGEMENT OF ADULT ASTHMATIC PATIENTS WHO ARE NOT ADEQUATELY CONTROLLED WITH INHALED CORTICOSTEROIDS MONOTHERAPY, WHICH IS MORE BENEFICIAL: ADDING A LONG ACTING BETA2 AGONIST OR A LONG ACTING MUSCARINIC ANTAGONIST?

Journal: Arerugi = [Allergy]
Published: November 15, 2023

Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging.

Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging.

Journal: Kidney international
Published: May 28, 2023

Economic costs for outpatient treatment of eating disorders in Japan.

Economic costs for outpatient treatment of eating disorders in Japan.

Journal: Journal of eating disorders
Published: April 16, 2023

Insights into the Regulation of GFR by the Keap1-Nrf2 Pathway.

Insights into the Regulation of GFR by the Keap1-Nrf2 Pathway.

Journal: Kidney360
Published: August 09, 2022

Endothelial Dysfunction Accelerates Impairment of Mitochondrial Function in Ageing Kidneys via Inflammasome Activation.

Endothelial Dysfunction Accelerates Impairment of Mitochondrial Function in Ageing Kidneys via Inflammasome Activation.

Journal: International journal of molecular sciences
Published: July 27, 2021

Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia.

Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia.

Journal: PloS one
Published: February 02, 2021

Hypercalcemia Associated with Extramammary Paget's Disease.

Hypercalcemia Associated with Extramammary Paget's Disease.

Journal: Case reports in oncology
Published: July 23, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026